D
Debbie Hagins
Publications - 2
Citations - 468
Debbie Hagins is an academic researcher. The author has contributed to research in topics: Cabotegravir & Integrase inhibitor. The author has an hindex of 2, co-authored 2 publications receiving 411 citations.
Papers
More filters
Journal ArticleDOI
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study.
Pedro Cahn,Anton Pozniak,Horacio Mingrone,Andrey Shuldyakov,Carlos Brites,Jaime Andrade-Villanueva,Gary Richmond,Carlos Beltran Buendia,Jan Fourie,Moti Ramgopal,Debbie Hagins,Franco Felizarta,José Valdez Madruga,Tania Reuter,Tamara Newman,Catherine B. Small,John Lombaard,Beatriz Grinsztejn,David Dorey,Mark R. Underwood,Sandy Griffith,Sherene Min +21 more
TL;DR: Once-daily dolutegravir, in combination with up to two other antiretroviral drugs, is well tolerated with greater virological effect compared with twice-daily raltegravIR in this treatment-experienced patient group.
Journal ArticleDOI
Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults
Scott Letendre,Anthony Mills,Debbie Hagins,Susan Swindells,Franco Felizarta,Jerome deVente,Christopher J Bettacchi,Yu Lou,Susan L. Ford,Kenneth Sutton,Jafar Sadik Shaik,Herta Crauwels,Ronald D'Amico,Parul Patel +13 more
TL;DR: A dual regimen of cabotegravir LA and rilpivirine LA achieved therapeutic concentrations in the CSF resulting in effective virological control in CSF.